Drug & intervention

pramlintide acetate

RxCUI 356773

Clinical trials19
Recruiting0
Related conditions11
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

19 shown
Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 DiabetesNCT04243629 · 2021-11-12
UNKNOWN
Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial PancreasNCT04163874 · 2020-02-14
COMPLETED
Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes MellitusNCT02500979 · 2015-08-17
COMPLETED
Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DMNCT01708044 · 2012-11-01
COMPLETED
Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DMNCT00732147 · 2009-04-01
WITHDRAWN
Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight SubjectsNCT00673387 · 2008-04-01
COMPLETED
A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese SubjectsNCT00402077 · 2006-11-01
COMPLETED
A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes MellitusNCT00313183 · 2006-04-01
COMPLETED
A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 DiabetesNCT00240253 · 2005-10-01
COMPLETED
An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 DiabetesNCT00229658 · 2005-09-01
COMPLETED
A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese SubjectsNCT00189514 · 2005-09-01
COMPLETED
A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese SubjectsNCT00112021 · 2005-05-01
COMPLETED
Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese SubjectsNCT00444561 · 2004-08-01
COMPLETED
Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes MellitusNCT00108004 · 2003-04-01
COMPLETED
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes MellitusNCT00107107 · 2002-11-01
COMPLETED
Evaluation of an Orally Administered Medication When Taken in Conjunction With PramlintideNCT00044707 · 2002-08-01
COMPLETED
Evaluation of the Effect of Pramlintide on Satiety and Food IntakeNCT00042601 · 2002-07-01
COMPLETED
Evaluation of the Bioavailability of PramlintideNCT00042471 · 2002-06-01
COMPLETED
Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose ControlNCT00042458 · 2002-04-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.